Jae Lyun Lee (Jae-Lyun Lee)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Yonsei medical journal

Investigative and clinical urology

Asia-Pacific journal of clinical oncology

University of Ulsan College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Ulsan College of Medicine Sep 01 2005 - Feb 10 2008

South Korea

PHD :: Medicine, Oncology

Yeungnam University College of Medicine Sep 01 2001 - Aug 25 2005

South Korea

MSC :: Internal Medicine

Publications

Se Un Jeong, Ja-Min Park, Sun Young Yoon, Hee Sang Hwang, Heounjeong Go, Dong-Myung Shin, Hyein Ju, Chang Ohk Sung, Jae Lyun Lee, Gowun Jeong, Young Mee Cho
IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and clinical urology 65 (1) (2024)
Se Un Jeong, Ja-Min Park, Sun Young Yoon, Hee Sang Hwang, Heounjeong Go, Dong-Myung Shin, Hyein Ju, Chang Ohk Sung, Jae Lyun Lee, Gowun Jeong, Young Mee Cho
IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and clinical urology 65 (1) (2024)
Se Un Jeong, Ja-Min Park, Sun Young Yoon, Hee Sang Hwang, Heounjeong Go, Dong-Myung Shin, Hyein Ju, Chang Ohk Sung, Jae Lyun Lee, Gowun Jeong, Young Mee Cho
IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma. Investigative and clinical urology 65 (1) (2024)
William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Sang Joon Shin, Jae Lyun Lee, Niven Mehra, Ray S McDermott, Núria Sala-Gonzalez, Peter C Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yanez, Eric Yi-Hsiu Huang, Stephen D Begbie, Rustem Airatovich Gafanov, Maria De Santis, Eli Rosenbaum, Michael P Kolinsky, Felipe Rey, Kun-Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian H Poehlein, Evan Y Yu
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kownoh Park, Jin Young Kim, Inkeun Park, Seong Hoon Shin, Kyungmin Lee, Jae Lyun Lee
Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei medical journal 64 (2) (2023)
Kownoh Park, Jin Young Kim, Inkeun Park, Seong Hoon Shin, Kyungmin Lee, Jae Lyun Lee
Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei medical journal 64 (2) (2023)
Alexandra Drakaki, Thomas Powles, Aristotelis Bamias, Juan Martín-Liberal, Sang Joon Shin, Terence W Friedlander, Diego Tosi, Chandler Park, Carlos Alberto Gomez Roca, Florence Joly Lobbedez, Daniel Castellano, Rafael Morales-Barrera, Irene Moreno-Candilejo, Aude Flechon, Kobe Yuen, Deepali Rishipathak, Kelly DuPree, Fiona Young, Francesca Michielin, Colby S Shemesh, Elizabeth E Steinberg, Patrick Williams, Jae Lyun Lee
Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Randomized Umbrella Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan Case, Christopher M Murawsky, Bram Estes, Gregory L Moore, Matthew J Bernett, Umesh S Muchhal, John R Desjarlais, Binnaz K Staley, Jennitte L Stevens, Keegan S Cooke, Famke Aeffner, Oliver Thomas, Julia Stieglmaier, Jae Lyun Lee, Angela Coxon, Julie M Bailis
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. Cancer discovery (2023)
Kownoh Park, Jin Young Kim, Inkeun Park, Seong Hoon Shin, Kyungmin Lee, Jae Lyun Lee
Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei medical journal 64 (2) (2023)
Masatoshi Eto, Jae Lyun Lee, Yen-Hwa Chang, Seasea Gao, Manmohan Singh, Howard Gurney
Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region. Asia-Pacific journal of clinical oncology 18 (5) (2022)
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, Hiroyuki Nishiyama, Andrea Necchi, Howard Gurney, Jae Lyun Lee, Michiel S Van Der Heijden, Eli Rosenbaum, Nicolas Penel, See-Tong Pang, Jian-Ri Li, Xavier García Del Muro Solans, Florence Joly Lobbedez, Zsuzsanna Pápai, Weichao Bao, Peter Ellinghaus, Chengxing Lu, Mitchell Sierecki, Sabine Coppieters, Keiko Nakajima, Tatiane Cristine Ishida, David I Quinn
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1 / 3 mRNA Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rae Na, Jinyoung Hong, Hyunjung Gu, Woochang Lee, Jae Lyun Lee, Sail Chun, Won-Ki Min
RNA Sequencing Provides Evidence for Pathogenicity of a Novel CHEK2 Splice Variant (C.1009-7T>G). Annals of laboratory medicine 42 (3) (2022)
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, Miguel A Climent, Daniel P Petrylak, Jae Lyun Lee, Lawrence Fong, Andrea Necchi, Cora N Sternberg, Peter H O'Donnell, Thomas Powles, Elizabeth R Plimack, Dean F Bajorin, Arjun V Balar, Daniel Castellano, Toni K Choueiri, Stephane Culine, Winald R Gerritsen, Howard Gurney, David I Quinn, Jacqueline Vuky, Nicholas J Vogelzang, Razvan Cristescu, Jared Lunceford, Assieh Saadatpour, Andrey Loboda, Junshui Ma, Mohini Rajasagi, James Luke Godwin, Blanca Homet Moreno, Petros D Grivas
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
David F McDermott, Jae Lyun Lee, Georg Arnold Bjarnason, James M G Larkin, Rustem Airatovich Gafanov, Mark D Kochenderfer, Niels Viggo Jensen, Frede Donskov, Jahangeer Malik, Alexandr Poprach, Scott S Tykodi, Teresa Alonso-Gordoa, Daniel C Cho, Poul F Geertsen, Miguel Angel Climent Duran, Christopher DiSimone, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Inhwan Hwang, Inkeun Park, Shin-Kyo Yoon, Jae Lyun Lee
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor. Asia-Pacific journal of clinical oncology (2021)
Ja Young Seo, Jeong-Yeal Ahn, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Jae Lyun Lee, Kownoh Park, Inkeun Park
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients. Annals of laboratory medicine 41 (2) (2021)
David F McDermott, Jae Lyun Lee, Marek Ziobro, Cristina Suarez, Przemyslaw Langiewicz, Vsevolod Borisovich Matveev, Pawel Wiechno, Rustem Airatovich Gafanov, Piotr Tomczak, Frederic Pouliot, Frede Donskov, Boris Yakovlevich Alekseev, Sang Joon Shin, Georg Arnold Bjarnason, Daniel Castellano, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Yongjune Lee, Young Seok Kim, Bumsik Hong, Yong Mee Cho, Jae Lyun Lee
Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC. Journal of cancer research and clinical oncology 147 (11) (2021)
Tie Zhou, Fangjian Zhou, Jianming Guo, Hongcheng Shi, Xudong Yao, Hongqian Guo, Jian Yuan, Ye Tian, Xiaodong Zhang, Shuxia Wang, Yongguang Jiang, Qing Zou, Daqing Zhou, Hanzhong Li, Fang Li, Jae Lyun Lee, Chung-Hsin Chen, Se Hoon Park, Quan Sing Ng, Jianhui Ma, Rong Zheng, Qiang Ding, Xingdang Liu, Rui Li, Heiko Krissel, Volker J Wagner, Yinghao Sun
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study. Asia-Pacific journal of clinical oncology 17 (6) (2020)
Hee Sang Hwang, Yun Yong Park, Su-Jin Shin, Heounjeong Go, Ja-Min Park, Sun Young Yoon, Jae Lyun Lee, Young Mee Cho
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma. Journal of Korean medical science 35 (5) (2020)
David S Hong, Yoon-Koo Kang, Mitesh Borad, Jasgit Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew J Brenner, Keunchil Park, Jae Lyun Lee, Tae-You Kim, Sangjoon Shin, Carlos R Becerra, Gerald Falchook, Jay Stoudemire, Desiree Martin, Kevin Kelnar, Heidi Peltier, Vinicius Bonato, Andreas G Bader, Susan Smith, Sinil Kim, Vincent O'Neill, Muhammad S Beg
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. British journal of cancer 122 (11) (2020)

Jae Lyun Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Jae-Lyun Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

Jae Lyun Lee (Jae-Lyun Lee)